Physician

Alisa Paliy, MD

According to 2025 Medicare claims, Alisa Paliy, MD (NPI: 1609263599) practices psychiatry in the Durham-Chapel Hill, NC market, with the plurality of this provider's patient population coming from Durham, NC. This provider's primary affiliated billing organization is DUKE HEALTH INTEGRATED PRACTICE, INC. (NPI: 1205553369; TIN: 862109896) and primary practice location at 27704-2702. Paliy is affiliated with the Triad HealthCare Network, LLC. (ACO ID: D0209), participating under the REACH model.

Paliy's data goes back to 2015 and runs through 2024. For example, in 2023, this provider had 20 traditional Medicare patients, billed 53 HCPCS/CPT codes, and received $2,937 in Medicare payments. 2024 Part D data shows 2,022 prescription claims across 145 beneficiaries totaling $567,718 in drug costs, led by Ingrezza (Valbenazine Tosylate). Open Payments data shows 18 records totaling $1,542. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $1,166 to $2,937. Similarly, Part D prescription costs have moved sharply higher in recent years, from $1,002 to $567,718. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$1.7K$3.4K2017 Medicare payment: $1,166 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $2,871 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $1,425 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $3,406 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $2,797 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $2,937 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
20171212$1,166
20182830$2,871
20191414$1,425
2020N/RN/RN/R
20212260$3,406
20221743$2,797
20232053$2,937
2024N/RN/RN/R

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$284K$568K2015 Drug cost: $1,002 (USD; Tot_Drug_Cst)2016 Drug cost: $2,482 (USD; Tot_Drug_Cst)2017 Drug cost: $25,378 (USD; Tot_Drug_Cst)2018 Drug cost: $31,809 (USD; Tot_Drug_Cst)2019 Drug cost: $33,383 (USD; Tot_Drug_Cst)2020 Drug cost: $71,019 (USD; Tot_Drug_Cst)2021 Drug cost: $164,833 (USD; Tot_Drug_Cst)2022 Drug cost: $358,155 (USD; Tot_Drug_Cst)2023 Drug cost: $444,143 (USD; Tot_Drug_Cst)2024 Drug cost: $567,718 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/R19$1,002
20161534$2,482
201713118$25,378
201824343$31,809
201957469$33,383
2020781,092$71,019
2021941,487$164,833
20221111,968$358,155
20231331,807$444,143
20241452,022$567,718

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

No connected Part B code-level records for 2024.

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
IngrezzaValbenazine Tosylate21630$186,975
Invega SustennaPaliperidone Palmitate27802$70,537
RexultiBrexpiprazole23750$42,257
VraylarCariprazine Hcl18540$25,178
Lurasidone HclLurasidone Hcl25990$12,934

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.18$1,542Neuronetics, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Alisa Paliy, MD?

Tedicare shows public-source Medicare data for Alisa Paliy, MD (NPI 1609263599), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Alisa Paliy, MD have ACO affiliation data?

Alisa Paliy, MD is shown with ACO affiliation data for Triad HealthCare Network, LLC. (REACH, ACO ID D0209).

What billing organization is linked to Alisa Paliy, MD?

Alisa Paliy, MD is linked to DUKE HEALTH INTEGRATED PRACTICE, INC. (billing NPI 1205553369) in the available physician profile data.

Does Alisa Paliy, MD have Open Payments data?

Alisa Paliy, MD has 18 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.